Aradigm Corporation Announces Appointment Of Dr. Juergen Froehlich As Chief Medical Officer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (OTCBB:ARDM) (“Aradigm” or the “Company”) today announced that Juergen Froehlich, MD has been appointed as Aradigm’s Chief Medical Officer. He joins Aradigm from Vertex Pharmaceuticals where he was Head of Regulatory Affairs, overseeing global submissions and approvals under accelerated review timelines of Kalydeco (ivacaftor) and the granting of two Breakthrough Designations for the orphan indication of cystic fibrosis.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC